Collegium Pharmaceutical, Inc. logo — Healthier people. Stronger communities.

Collegium Pharmaceutical, Inc.

Healthier people. Stronger communities.

Founded 2002 United States Stoughton, United States 344 employees Post Ipo Debt Total: $309.20M Biotechnology, Health and Wellness +1

General Information

Company Name Collegium Pharmaceutical, Inc.
Founded Year 2002
Location United States Stoughton, United States
Founders / Decision Makers
Team member
Employees 344
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Post Ipo Debt
Social

Get notified when Collegium Pharmaceutical, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is a biotechnology company founded in 2002 with a mission to improve the lives of individuals facing severe medical conditions. The company boasts a diversified portfolio of innovative medications. The United States-based company recently secured a significant $203.20M post-IPO debt investment on 07 February 2023.

Collegium Pharmaceutical emphasizes its commitment to enhancing the well-being of individuals and strengthening communities, evident in their slogan, "Healthier people. Stronger communities." The recent substantial investment further underscores the company's potential to carve a prominent position in the pharmaceutical landscape.

Taxonomy: pharmaceuticals, specialty pharmaceuticals, chronic pain management, patent-protected formulations, drug abuse prevention, tamper-resistant features, IP protection, late-stage pharmaceuticals, medical conditions, extended-release delivery, proprietary medications, responsible pain management, intellectual property, pharmaceutical development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 07 Feb 2023
Private Equity Round •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor Investor
•••• ••••
10 Mar 2015
Grant •••••• 1
Investor
07 Aug 2014
Venture Round •••••• - 02 Oct 2013
Series B •••••• 4
Investor Investor Investor Investor
15 Feb 2012

View All 9 Funding Rounds

Collegium Pharmaceutical, Inc. Alternatives & Competitors

Collegium Pharmaceutical, Inc. vs

Developing novel pharmacological hydrogel treatments for chronic pain conditions in urgent need of s...

Pre Seed
3 employees
Biotechnology, Pharmaceutical
Collegium Pharmaceutical, Inc. vs

Pioneering novel therapies to address cancer and metabolic disorders by targeting essential cellular...

Debt Financing
Biotechnology, Health Care
Collegium Pharmaceutical, Inc. vs
Flarin
Flarin United Kingdom

Highly Effective Joint Pain Relief, Unique Lipid Formulation

Series Unknown
1 employees
Health Care, Pharmaceutical

FAQ About Collegium Pharmaceutical, Inc.

Healthier people. Stronger communities.
Collegium Pharmaceutical, Inc. was founded in 2002.
Collegium Pharmaceutical, Inc. is headquartered in Stoughton, United States.
Collegium Pharmaceutical, Inc. operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Collegium Pharmaceutical, Inc. has approximately 344 employees.
Collegium Pharmaceutical, Inc. has completed 9 funding rounds, raising a total of $309.20M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Collegium Pharmaceutical, Inc. include Relevium Medical, Petra Pharma, Flarin, Prizm Pain Specialists, Zogenix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Collegium Pharmaceutical, Inc. and Relevium Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Collegium Pharmaceutical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy